-
Je něco špatně v tomto záznamu ?
The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population
Z. Kleibl, O. Havránek, I. Hlavatá, J. Novotný, J. Ševčík, P. Pohlreich, P. Souček
Jazyk angličtina Země Velká Británie
- MeSH
- dědičné nádorové syndromy genetika MeSH
- delece genu MeSH
- dospělí MeSH
- financování organizované MeSH
- genetická predispozice k nemoci MeSH
- kolorektální nádory genetika patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mutace MeSH
- mutační analýza DNA metody MeSH
- protein-serin-threoninkinasy genetika MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- staging nádorů MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
Checkpoint kinase 2 (CHEK2) gene codes for an important mediator of DNA damage response pathway. Its mutations increase risk of several types of cancer. We analysed selected CHEK2 mutations in 631 Czech colorectal cancer (CRC) patients. The increased risk of CRC was associated with mutations in CHEK2 gene region involving fork head-associated domain [39/631 (6.2%) cases versus 19/683 (2.8%) controls; odds ratio (OR)=2.3; 95% confidence interval (CI)=1.3-4.0; p=0.003], and with the most frequent I157T mutation [30/631 (4.8%) cases versus 17/683 (2.5%) controls; OR=2.0; 95% CI=1.1-3.6; p=0.03]. Prevalence of 1100delC mutation in CRC patients (4/631) did not differ from that in the control population (2/730; p=0.4). The deletion of 5395 bp was not found in any of the successfully analysed CRC cases. We observed no association of analysed mutations with CRC family history. We conclude that the I157T and other alterations in its proximity predispose to sporadic but not to familial CRC in the Czech population.
Citace poskytuje Crossref.org
- 000
- 02802naa 2200469 a 4500
- 001
- bmc11009711
- 003
- CZ-PrNML
- 005
- 20221005130014.0
- 008
- 110511s2009 xxk e eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejca.2008.09.022 $2 doi
- 035 __
- $a (PubMed)18996005
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kleibl, Zdeněk, $d 1969- $7 jo2003183974
- 245 14
- $a The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population / $c Z. Kleibl, O. Havránek, I. Hlavatá, J. Novotný, J. Ševčík, P. Pohlreich, P. Souček
- 314 __
- $a Institute of Biochemistry and Experimental Oncology, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. zdekleje@lf1.cuni.cz
- 520 9_
- $a Checkpoint kinase 2 (CHEK2) gene codes for an important mediator of DNA damage response pathway. Its mutations increase risk of several types of cancer. We analysed selected CHEK2 mutations in 631 Czech colorectal cancer (CRC) patients. The increased risk of CRC was associated with mutations in CHEK2 gene region involving fork head-associated domain [39/631 (6.2%) cases versus 19/683 (2.8%) controls; odds ratio (OR)=2.3; 95% confidence interval (CI)=1.3-4.0; p=0.003], and with the most frequent I157T mutation [30/631 (4.8%) cases versus 17/683 (2.5%) controls; OR=2.0; 95% CI=1.1-3.6; p=0.03]. Prevalence of 1100delC mutation in CRC patients (4/631) did not differ from that in the control population (2/730; p=0.4). The deletion of 5395 bp was not found in any of the successfully analysed CRC cases. We observed no association of analysed mutations with CRC family history. We conclude that the I157T and other alterations in its proximity predispose to sporadic but not to familial CRC in the Czech population.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a kolorektální nádory $x genetika $x patologie $7 D015179
- 650 _2
- $a mutační analýza DNA $x metody $7 D004252
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a delece genu $7 D017353
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a dědičné nádorové syndromy $x genetika $7 D009386
- 650 _2
- $a protein-serin-threoninkinasy $x genetika $7 D017346
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Havránek, Ondřej. $7 xx0128548
- 700 1_
- $a Hlavatá, Ivona. $7 _AN063454
- 700 1_
- $a Novotný, Jan, $d 1971- $7 jo2003184375
- 700 1_
- $a Ševčík, Jan $7 xx0114516
- 700 1_
- $a Pohlreich, Petr, $d 1947-2015 $7 jn20000710479
- 700 1_
- $a Souček, Pavel $7 xx0060511
- 773 0_
- $t European Journal of Cancer $g Roč. 45, č. 4 (2009), s. 618-624 $w MED00009626
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110513110744 $b ABA008
- 991 __
- $a 20221005130009 $b ABA008
- 999 __
- $a ok $b bmc $g 839126 $s 703104
- BAS __
- $a 3
- BMC __
- $a 2009 $b 45 $c 4 $d 618-624 $m European journal of cancer $n Eur J Cancer $x MED00009626
- LZP __
- $a 2011-2B09/jvme